Position in PTGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,552,192
+$2,128,132 QoQ
Shares Held
102,400
+3.5% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 343 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. PTGX ranks #26 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in PTGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,552,192 | 102,400 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,424,060 | 98,900 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,576,788 | 98,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,383,923 | 96,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,184,326 | 93,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,202,484 | 86,900 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,354,340 | 86,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,865,500 | 85,900 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,976,435 | 85,900 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,623,951 | 90,700 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,079,751 | 90,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,678,008 | 100,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,706,760 | 98,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,833,100 | 79,700 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $969,899 | 88,900 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $729,195 | 86,500 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $666,813 | 84,300 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,403,520 | 101,500 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,221,640 | 94,200 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,548,728 | 87,400 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,895,584 | 86,800 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,165,240 | 83,600 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,667,232 | 82,700 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||